Latest Headlines
-
Neurocode Launches Groundbreaking pTau217 Blood Test For Alzheimer's Disease Clinical Diagnosis
3/4/2024
Neurocode USA, Inc, a specialized clinical laboratory that offers world-class testing solutions for neurological disorders, is pleased to announce the clinical launch of ALZpath Dx, an innovative and novel blood test that can be used in the screening, diagnosis, and monitoring of Alzheimer's disease (AD) based on circulating level of pTau217 in the blood.
-
Bruker Announces Share Purchase Agreement To Acquire Molecular Diagnostics Innovator ELITechGroup
2/28/2024
Bruker Corporation announced today that it has entered into a definitive share purchase agreement with TecFin S.à r.l., a controlled affiliate of PAI Partners, a pre-eminent private equity firm, to acquire ELITechGroup, for €870M in cash, excluding the carved out ELITech clinical chemistry business.
-
Emeritusdx Receives Clinical Laboratory Permit From New York State Department Of Health, Expanding Service Nationwide
2/28/2024
EmeritusDX, a rapidly growing cancer diagnostics and information company, is proud to announce that it has been granted a Clinical Laboratory Permit by the New York State Department of Health.
-
Ginkgo Bioworks Acquires Reverie Labs Platform, Enhancing AI-Driven Drug Discovery Capabilities For Customer Programs
2/28/2024
Today, Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced the acquisition of key assets of Reverie Labs, which built and used AI/ML tools to accelerate drug discovery.
-
Know Labs Announces The KnowU, Its Wearable Non-Invasive Continuous Glucose Monitor
2/27/2024
Know Labs, Inc., an emerging developer of non-invasive medical diagnostic technology, today announced the KnowU, its wearable non-invasive continuous glucose monitor (CGM). The Company announced its first prototype in June 2023.
-
Pramana Joins Proscia Ready To Help Laboratories Realize More Value From Their Pathology Data
2/27/2024
Proscia®, a leading provider of digital and computational pathology solutions, today announced that Pramana, Inc., an AI-enabled health tech company modernizing the pathology sector, is now a Proscia Ready partner.
-
Quanterix Announces First Collaborations With Five Health Networks To Aid The Diagnosis And Clinical Management Of Individuals With Alzheimer’s Disease
2/26/2024
Quanterix Corporation, a leading provider of ultra-sensitive research products and high-definition diagnostics, today announced its first collaborations with health systems in pursuit of their shared goal to improve and simplify Alzheimer’s disease (AD) diagnosis.
-
DiaCarta, Inc. And OncoAssure Ltd. Collaborate To Launch Prostate Cancer Lab Developed Test
2/26/2024
DiaCarta, Inc. ("DiaCarta"), a pioneer in molecular diagnostic test development for cancer and infectious diseases, today announced that it has established a strategic collaboration with OncoAssure Ltd, an Irish medical diagnostics company.
-
Naveris Announces Commercial Payor Coverage For NavDx Test From Highmark, Inc.
2/22/2024
Naveris, Inc., the leader in precision oncology diagnostics for viral-induced cancers, today announced that Highmark Inc.
-
Scientists Develop A Simple Blood Test To Quickly Diagnose Sarcoidosis
2/22/2024
A research project supported by the National Institutes of Health has developed a tool to rapidly and inexpensively diagnose sarcoidosis, a chronic inflammatory disease marked by the growth of tiny lumps called granulomas in the lungs and other organs in the body.